Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 16
2020 20
2021 20
2022 12
2023 15
2024 41
2025 29
2026 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

171 results

Results by year

Filters applied: . Clear all
Page 1
Perceptions of young people living with HIV and caregivers in Botswana on analytical treatment interruption studies: a qualitative approach.
Koofhethile CK, Kebaabetswe P, Choga OT, Ditshweu F, Ntshonga P, Molefe BR, Batlang O, Mokgethi P, Mosielele T, Sabone P, Kgoreletso P, Gouwe A, Mosepele K, Majola R, Maruapula D, Seatla K, Choga W, Ajibola G, Makhema J, Masheto G, Yu X, Moyo S, Lichterfeld M, Lockman S, Shapiro R. Koofhethile CK, et al. HIV Res Clin Pract. 2026 Dec 31;27(1):2673739. doi: 10.1080/25787489.2026.2673739. Epub 2026 May 20. HIV Res Clin Pract. 2026. PMID: 42163437 Free article.
Utility of the brief Patient Health Questionnaire-2 and Generalized Anxiety Disorder-2 screeners for depression and generalized anxiety symptom identification in people with human immunodeficiency virus.
Lee GY, Latimer MC, Kelly SM, Verinumbe T, Agee T, Hutton H, Lesko C, Jones J, Schwartz S, Hsu J, Falade-Nwulia O. Lee GY, et al. HIV Res Clin Pract. 2026 Dec 31;27(1):2616103. doi: 10.1080/25787489.2026.2616103. Epub 2026 Jan 21. HIV Res Clin Pract. 2026. PMID: 41566210 Free article.
Impact of analytical treatment interruptions on sexual behaviors: a mixed-methods longitudinal study of women enrolled in an HIV cure-related trial in Durban, South Africa.
Dubé K, Ngcobo MW, Ahmed A, Hussain M, Langa N, Zulu A, Maphalala L, Pillay V, Mthembu M, Wan F, Tran W, Lau R, Stockman JK, Ndung'u T, Dong KL. Dubé K, et al. HIV Res Clin Pract. 2025 Dec 31;26(1):2599070. doi: 10.1080/25787489.2025.2599070. Epub 2025 Dec 9. HIV Res Clin Pract. 2025. PMID: 41369160 Free PMC article.
Prevalence and predictors of virological failure among the people living with HIV on antiretroviral treatment in East Africa: evidence from a systematic review with meta-analysis and meta-regression of published studies from 2016 to 2023.
Namaganda MM, Mukasa Kafeero H, Nakatumba Nabende J, Kateete DP, Batte C, Wanyengera M, Jjingo D, Joloba M, Kivunike F, Ssewanyana I, Miya Y, Kato D, Ouma S, Kakembo FE, Kanyerezi S, Kabahiita JM, Muwanda F, Mboowa G. Namaganda MM, et al. HIV Res Clin Pract. 2025 Dec;26(1):2490774. doi: 10.1080/25787489.2025.2490774. Epub 2025 Apr 11. HIV Res Clin Pract. 2025. PMID: 40219653 Free PMC article.
Bictegravir/emtricitabine/tenofovir alafenamide in clinical practice for people with HIV: final 24-month effectiveness and safety outcomes in key populations in the observational BICSTaR cohort.
Trottier B, Yang CJ, Watanabe D, Marchetti G, Elbirt D, De Barra E, Gündüz A, Lee SH, Vogelmann R, Robineau O, Choy CY, Berrevoets M, Uriel A, Thorpe D, Heinzkill M, Marongiu A, Ramroth J, D'Amato L, Mallolas J. Trottier B, et al. HIV Res Clin Pract. 2025 Dec;26(1):2456890. doi: 10.1080/25787489.2025.2456890. Epub 2025 Feb 12. HIV Res Clin Pract. 2025. PMID: 39936702 Free article.
'It is scary to pause treatment': perspectives on HIV cure-related research and analytical treatment interruptions from women diagnosed during acute HIV in Durban, South Africa.
Mthimkhulu D, Dong KL, Ngcobo MW, Mindry D, Zulu A, Langa N, Maphalala L, Pillay V, Mthembu M, Miall A, Tran W, Dillen A, Wan F, Ahmed A, Stockman JK, Hussain M, Ndung'u T, Dubé K. Mthimkhulu D, et al. HIV Res Clin Pract. 2025 Dec;26(1):2455917. doi: 10.1080/25787489.2025.2455917. Epub 2025 Jan 25. HIV Res Clin Pract. 2025. PMID: 39862155 Free PMC article.
Barriers to HIV rapid start among New Jersey providers.
Mohammed DY, Brewer R, Leider J, Martin E, Choe S. Mohammed DY, et al. HIV Res Clin Pract. 2024 Dec;25(1):2402140. doi: 10.1080/25787489.2024.2402140. Epub 2024 Sep 25. HIV Res Clin Pract. 2024. PMID: 39319555 Free article.
Assessment of the HIV Enhanced Access Testing in the Emergency Department (HEATED) program in Nairobi, Kenya: a quasi-experimental prospective study.
Aluisio AR, Smith-Sreen J, Offorjebe A, Maina W, Pirirei S, Kinuthia J, Bukusi D, Waweru H, Bosire R, Ojuka DK, Eastment MC, Katz DA, Mello MJ, Farquhar C. Aluisio AR, et al. HIV Res Clin Pract. 2024 Dec;25(1):2403958. doi: 10.1080/25787489.2024.2403958. Epub 2024 Sep 18. HIV Res Clin Pract. 2024. PMID: 39290079 Free PMC article.
The prevalence of vertical transmission of human immunodeficiency virus and associated factors among exposed infants in Eastern Lake zone and Southern Highland of Tanzania: a cross-sectional study.
Torokaa PR, Urio L, Mwakalobo A, Eriyo G, Magesa AS, Julius R, Kyalo A, Allan JN, Osima DJ, Shao FM, Mziray J, Mtui L, Mbago TP, Robert M, Nyamhagatta MA, Msangi M, Chacha M, Charles H, Mtui GD, Majigo M, Joachim A. Torokaa PR, et al. HIV Res Clin Pract. 2024 Dec;25(1):2378575. doi: 10.1080/25787489.2024.2378575. Epub 2024 Jul 16. HIV Res Clin Pract. 2024. PMID: 39012073 Free article.
Evaluating knowledge, practice, and attitude of Syrian population on sexually transmitted infections and human immunodeficiency virus.
Swed S, Alibrahim H, Albakri K, Rais MA, Al-Rassas S, Hafez W, Sawaf B, Almoshantaf MB, Elsayed M, Albazee E, Cheema HA, Hraiz W, Taieb F, Ameen VH, Rakab A, Emran TB, AbdElrahim E, Osman H, Khan Pathan R, Khandaker MU. Swed S, et al. HIV Res Clin Pract. 2024 Dec;25(1):2356409. doi: 10.1080/25787489.2024.2356409. Epub 2024 Jul 13. HIV Res Clin Pract. 2024. PMID: 39001878 Free article.
A telehealth-delivered intervention to extend the veteran HIV treatment cascade for cardiovascular disease prevention: V-EXTRA-CVD study protocol for a randomized controlled trial.
Musoke L, Bosworth HB, Dickson C, Gentry P, Strawbridge E, Subramaniam S, Gierisch J, Smith V, Woolson S, Pura J, Amutuhaire W, Naggie S, Schexnayder J, Hall K, Longenecker CT, Harris NM, Rogers C, Van Epps P; for V-EXTRA-CVD Group. Musoke L, et al. HIV Res Clin Pract. 2023 Dec;24(1):2261747. Epub 2023 Oct 6. HIV Res Clin Pract. 2023. PMID: 37800987
Increasing the meaningful involvement of women in HIV cure-related research: a qualitative interview study in the United States.
Dubé K, Barr E, Philbin M, Perez-Brumer A, Minalga B, Peterson B, Averitt D, Picou B, Martel K, Chung C, Mejía M, Cameron M, Graham G, Dee L, Dixon Diallo D, Gordon E, Korolkova A, Dyer T, Auerbach JD, Scully E, Dong KL, Gianella S. Dubé K, et al. HIV Res Clin Pract. 2023 Aug 8;24(1):2246717. HIV Res Clin Pract. 2023. PMID: 37608645 Free PMC article.
"We are looking at the future right now": community acceptability of a home-based viral load test device in the context of HIV cure-related research with analytical treatment interruptions in the United States.
Dubé K, Kanazawa J, Roebuck C, Johnson S, Carter WB, Dee L, Peterson B, Lynn KM, Lalley-Chareczko L, Hiserodt E, Kim S, Rosenbloom D, Evans BR, Anderson M, Hazuda DJ, Shipley L, Bateman K, Howell BJ, Mounzer K, Tebas P, Montaner LJ. Dubé K, et al. HIV Res Clin Pract. 2022 Dec;23(1):120-135. Epub 2022 Mar 29. HIV Res Clin Pract. 2022. PMID: 35348047 Free PMC article.
Participant experiences using novel home-based blood collection device for viral load testing in HIV cure trials with analytical treatment interruptions.
Dubé K, Agarwal H, Carter WB, Dee L, Taylor J, Roebuck C, Peterson B, Patel H, Ndukwe S, Lynn KM, Lalley-Chareczko L, Hiserodt E, Kim S, Rosenbloom D, Evans BR, Anderson M, Hazuda DJ, Bateman K, Howell BJ, Azzoni L, Mounzer K, Tebas P, Montaner LJ. Dubé K, et al. HIV Res Clin Pract. 2022 Aug 2;23(1):76-90. HIV Res Clin Pract. 2022. PMID: 35968737 Free PMC article.
Adaption of an ongoing clinical trial to quickly respond to gaps in changing international recommendations: the experience of D2EFT.
Papot E, Jacoby S, Arlinda D, Avihingsanon A, Azwa I, Borok M, Brown D, Cissé M, Dao S, Eriobu N, Kaplan R, Karyana M, Kumarasamy N, Lee J, Losso MH, Matthews GV, Perelis L, Perez-Casas C, Ruxrungtham K, Watkins M, Lane HC, Kelleher A, Law M, Polizzotto MN; D2EFT Study Group. Papot E, et al. HIV Res Clin Pract. 2022 Jul 19;23(1):37-46. HIV Res Clin Pract. 2022. PMID: 35938597 Free PMC article. Clinical Trial.
Switching to a NRTI-free 2 drug regimen (2DR) -a sub-analysis of the 48 weeks DUALIS study on metabolic and renal changes.
Monin M, Kümmerle T, Schneider J, Cordes C, Heiken H, Stellbrink HJ, Krznaric I, Scholten S, Jensen B, Jessen H, Obst W, Spornraft-Ragaller P, Khaykin P, Balogh A, Wolf E, Bidner H, Spinner CD, Boesecke C; DUALIS STUDY GROUP. Monin M, et al. HIV Res Clin Pract. 2021 Dec 23;23(1):15-21. Epub 2022 Mar 2. HIV Res Clin Pract. 2021. PMID: 35234092 Clinical Trial.
Impact of treatment adherence on efficacy of dolutegravir plus lamivudine and dolutegravir plus tenofovir disoproxil fumarate/emtricitabine: pooled analysis of the GEMINI-1 and GEMINI-2 clinical studies.
Ait-Khaled M, Sierra Madero J, Estrada V, Gulminetti R, Hagins D, Tsai HC, Man C, Sievers J, Grove R, Zolopa A, Wynne B, van Wyk J. Ait-Khaled M, et al. HIV Res Clin Pract. 2021 Dec 9;23(1):9-14. Epub 2021 Dec 16. HIV Res Clin Pract. 2021. PMID: 34913844 Clinical Trial.
Hypersensitivity reactions, hepatotoxicity, and other discontinuations in persons receiving integrase strand transfer inhibitors: results from the EuroSIDA study.
Pelchen-Matthews A, Larsen JF, Shepherd L, Begovac J, Pedersen K, De Wit S, Horban A, Jablonowska E, Johnson M, Khromova I, Losso MH, Nielsen LN, Ridolfo AL, Schmied B, Stephan C, Yust I, Curtis L, Vannappagari V, Ragone L, Roen A, Raben D, Kirk O, Peters L, Mocroft A; EuroSIDA Study Group. Pelchen-Matthews A, et al. HIV Res Clin Pract. 2021 Dec;22(6):160-168. Epub 2021 Nov 15. HIV Res Clin Pract. 2021. PMID: 34779362
A phase IV, open-label three-arm study investigating the impact of a combination of tenofovir disoproxil fumarate/emtricitabine with raltegravir or dolutegravir or elvitegravir/cobicistat on renal function in HIV-1 antiretroviral naïve patients.
Bracchi M, Pagani N, Dalla Pria A, Milinkovic A, Nwokolo N, Thomas L, Mandalia S, Boffito M, Moyle G. Bracchi M, et al. HIV Res Clin Pract. 2021 Oct;22(5):128-139. Epub 2021 Sep 22. HIV Res Clin Pract. 2021. PMID: 34551678 Clinical Trial.
HIV and COVID-19: review of clinical course and outcomes.
Barbera LK, Kamis KF, Rowan SE, Davis AJ, Shehata S, Carlson JJ, Johnson SC, Erlandson KM. Barbera LK, et al. HIV Res Clin Pract. 2021 Aug;22(4):102-118. doi: 10.1080/25787489.2021.1975608. Epub 2021 Sep 12. HIV Res Clin Pract. 2021. PMID: 34514963 Free PMC article.
eGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohort.
Teira R, Diaz-Cuervo H, Aragão F, Muñoz J, Galindo P, Merino M, de la Fuente B, Sepúlveda MA, Domingo P, García J, Castaño M, Ribera E, Geijo P, Romero A, Peraire J, Deig E, Roca B, Martínez E, Estrada V, Montero M, Berenguer J, Espinosa N. Teira R, et al. HIV Res Clin Pract. 2021 Jun;22(3):78-85. Epub 2021 Aug 19. HIV Res Clin Pract. 2021. PMID: 34410219
Week 96 subgroup analyses of the phase 3, randomized AMBER and EMERALD trials evaluating the efficacy and safety of the once daily darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) single-tablet regimen in antiretroviral treatment (ART)-naïve and -experienced, virologically-suppressed adults living with HIV-1.
Huhn GD, Wilkin A, Mussini C, Spinner CD, Jezorwski J, El Ghazi M, Van Landuyt E, Lathouwers E, Brown K, Baugh B; AMBER and EMERALD study groups. Huhn GD, et al. HIV Res Clin Pract. 2020 Dec;21(6):151-167. doi: 10.1080/25787489.2020.1844520. Epub 2021 Feb 2. HIV Res Clin Pract. 2020. PMID: 33528318 Free article. Clinical Trial.
Changes in central adipose tissue after switching to integrase inhibitors.
Debroy P, Feng H, Miao H, Milic J, Ligabue G, Draisci S, Besutti G, Carli F, Menozzi M, Mussini C, Guaraldi G, Lake JE. Debroy P, et al. HIV Res Clin Pract. 2020 Dec;21(6):168-173. doi: 10.1080/25787489.2020.1848131. Epub 2021 Jan 18. HIV Res Clin Pract. 2020. PMID: 33459579 Free PMC article.
Impact of extended-release niacin on immune activation in HIV-infected immunological non-responders on effective antiretroviral therapy.
Lebouché B, Yero A, Shi T, Farnos O, Singer J, Kema I, Costiniuk CT, Thomas R, Brouillette MJ, Engler K, Routy JP, Jenabian MA; CTN PT006 Study Group. Lebouché B, et al. HIV Res Clin Pract. 2020 Dec;21(6):182-190. doi: 10.1080/25787489.2020.1866846. Epub 2021 Jan 6. HIV Res Clin Pract. 2020. PMID: 33403940 Free article. Clinical Trial.
COVID-19 symptoms and SARS-CoV-2 infection among people living with HIV in the US: the MACS/WIHS combined cohort study.
D'Souza G, Springer G, Gustafson D, Kassaye S, Alcaide ML, Ramirez C, Sharma A, Palella FJ, Tien PC, Detels R, Kempf MC, Lahiri CD, Rinaldo CR, French AL, Margolick JB, Adimora AA. D'Souza G, et al. HIV Res Clin Pract. 2020 Oct;21(5):130-139. doi: 10.1080/25787489.2020.1844521. Epub 2020 Nov 19. HIV Res Clin Pract. 2020. PMID: 33211636 Free PMC article.
Examining the association between stress and antiretroviral therapy adherence among women living with HIV in Toronto, Ontario.
Benoit AC, Burchell AN, O'Brien KK, Raboud J, Gardner S, Light L, Beaver K, Cotnam J, Conway T, Price C, Rourke SB, Rueda S, Hart TA, Loutfy M; OHTN Cohort Study Team. Benoit AC, et al. HIV Res Clin Pract. 2020 Apr-Jun;21(2-3):45-55. doi: 10.1080/25787489.2020.1763711. Epub 2020 May 18. HIV Res Clin Pract. 2020. PMID: 32419657 Free article.
Successful recruitment of a multi-site international randomized placebo-controlled trial in people with HIV with attention to diversity of race and ethnicity: critical role of central coordination.
Fitch KV, Kileel EM, Looby SE, Zanni MV, Sanchez LR, Fichtenbaum CJ, Overton ET, Malvestutto C, Aberg JA, Klingman KL, Alston-Smith B, Lavelle J, Rancourt A, Badal-Faesen S, Cardoso SW, Avihingsanon A, Patil S, Sponseller CA, Melbourne K, Ribaudo HJ, Cooper-Arnold K, Desvigne-Nickens P, Hoffmann U, Douglas PS, Grinspoon SK; REPRIEVE Investigators. Fitch KV, et al. HIV Res Clin Pract. 2020 Feb;21(1):11-23. doi: 10.1080/25787489.2020.1733794. Epub 2020 Mar 11. HIV Res Clin Pract. 2020. PMID: 32160827 Free PMC article.
96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation.
Di Cristo V, Adorni F, Maserati R, Annovazzi Lodi M, Bruno G, Maggi P, Volpe A, Vitiello P, Abeli C, Bonora S, Ferrara M, Cossu MV, Oreni ML, Colella E, Rusconi S. Di Cristo V, et al. HIV Res Clin Pract. 2020 Feb;21(1):34-43. doi: 10.1080/25787489.2020.1734752. Epub 2020 Mar 4. HIV Res Clin Pract. 2020. PMID: 32129161 Free article. Clinical Trial.
Cenicriviroc, a dual CCR2 and CCR5 antagonist leads to a reduction in plasma fibrotic biomarkers in persons living with HIV on antiretroviral therapy.
Bowler S, Siriwardhana C, Mitchell BI, D'Antoni ML, Ogata-Arakaki D, Souza S, Yee R, Gangcuangco LMA, Chow DC, Ndhlovu LC, Shikuma C. Bowler S, et al. HIV Res Clin Pract. 2019 Aug-Oct;20(4-5):123-129. doi: 10.1080/25787489.2020.1719319. Epub 2020 Feb 4. HIV Res Clin Pract. 2019. PMID: 32013805 Free article. Clinical Trial.
Patient-reported tolerability and acceptability of cabotegravir + rilpivirine long-acting injections for the treatment of HIV-1 infection: 96-week results from the randomized LATTE-2 study.
Murray M, Pulido F, Mills A, Ramgopal M, LeBlanc R, Jaeger H, Canon V, Dorey D, Griffith S, Mrus J, Spreen W, Margolis D. Murray M, et al. HIV Res Clin Pract. 2019 Aug-Oct;20(4-5):111-122. doi: 10.1080/25787489.2019.1661696. Epub 2019 Sep 18. HIV Res Clin Pract. 2019. PMID: 31533539 Free article. Clinical Trial.
Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trials.
Kim YS, Oka S, Chetchotisakd P, Clarke A, Supparatpinyo K, Avihingsanon A, Ratanasuwan W, Kiertiburanakul S, Ruxrungtham K, Yang S, Guo S, Liu Y, Das M, Tran D, McColl D, Corales R, Nguyen C, Piontkowsky D. Kim YS, et al. HIV Res Clin Pract. 2019 Jun;20(3):73-81. doi: 10.1080/15284336.2019.1589232. Epub 2019 Jul 8. HIV Res Clin Pract. 2019. PMID: 31303140 Free article.
Study protocol for the targeting effective analgesia in clinics for HIV (TEACH) study - a cluster randomized controlled trial and parallel cohort to increase guideline concordant care for long-term opioid therapy among people living with HIV.
Lira MC, Tsui JI, Liebschutz JM, Colasanti J, Root C, Cheng DM, Walley AY, Sullivan M, Shanahan C, O'Connor K, Abrams C, Forman LS, Chaisson C, Bridden C, Podolsky MC, Outlaw K, Harris CE, Armstrong WS, Del Rio C, Samet JH. Lira MC, et al. HIV Res Clin Pract. 2019 Apr;20(2):48-63. doi: 10.1080/15284336.2019.1627509. HIV Res Clin Pract. 2019. PMID: 31303143 Free PMC article.
Quality of life of older women living with HIV: comparative assessment of physical and mental health-related markers using a large Canadian Sexual and Reproductive Health Cohort Study.
Kteily-Hawa R, Andany N, Wang Y, Logie CH, Tharao W, Conway T, Webster K, de Pokomandy A, Kaida A, Hogg R, Loutfy M; (as senior author) on behalf of the CHIWOS Research Team. Kteily-Hawa R, et al. HIV Res Clin Pract. 2019 Apr;20(2):35-47. doi: 10.1080/15284336.2018.1554373. HIV Res Clin Pract. 2019. PMID: 31303141 Free article.